CTEP Branches and Offices
Nayon Kang, PharmD, MSc
Senior Clinical Research Pharmacist
Dr. Kang received her PharmD from the University of Kentucky College of Pharmacy (UKCOP) in 2013 and completed a PGY-1 residency at Hartford Hospital in Connecticut. She also received a master's degree in clinical and experimental therapeutics from UKCOP in 2017.
After working as a clinical pharmacist at the University of Kentucky Healthcare, she transitioned to research and oncology pharmacy services at the Children's National Medical Center and then at MedStar Georgetown University Hospital, where she served as a pharmacy representative on the Data and Safety Monitoring Board. Prior to joining PMB, she worked as a contractor supporting the Division of Clinical Research at the National Institute of Allergy and Infectious Diseases, where she served as a research pharmacy advisor to designated national and international research pharmacies. During this time, she was a member of a drug-drug interaction (DDI) workgroup in developing a DDI database tool for a clinical trial.
About the Branch Chief (Acting)
Matthew J. Boron, RPh joined the Cancer Therapy Evaluation Program (CTEP) in 2000 as a Clinical Research Pharmacist in
the Drug Management and Authorization Section (DMAS) of the Pharmaceutical Management Branch (PMB), where he was
responsible for a portfolio of biologic agents under CTEP Investigational New Drug applications (INDs). In 2002, he
transitioned to management of the Treatment Referral Center (TRC). More…